Where does Sebastian Brunemeier work?

Sebastian Brunemeier is General Partner at Healthspan Capital.

What check size does Sebastian Brunemeier write?

Sebastian Brunemeier typically writes checks of $250K – $750K.

What companies has Sebastian Brunemeier invested in?

Investments tracked here include Cyclone Therapeutics, Jung+ Longevity, Oisin Biotechnologies.

Where did Sebastian Brunemeier go to school?

Sebastian Brunemeier studied at University of Oxford (PhD (DPhil) studies (ABD), Biochemistry of aging. Clarendon Scholarship); Scripps Research (Skaggs-Oxford Scholar Fellowship (joint PhD program with Oxford, awarded but paused)); University of Amsterdam (MSc, Biomedical Science (Molecular Neuroscience)).

Sebastian Brunemeier

Investor

General Partner at Healthspan Capital · Executive Officer, Director, Promoter at Cyclone Therapeutics

Oxford, United Kingdom

Writes $250K – $750K checks · typically $500K

Find your path to Sebastian

1,593 people in our graph can introduce you to Sebastian.

Each arrow is one introduction. Sign up to fill in the first one.

Ask Nick Schaum to introduce you to Sebastian

You →Nick · together at Buck Institute for Research on Aging (2012) →Sebastian

Ask Jamie Chen to introduce you to Sebastian

You →Jamie · together at Apollo Health Ventures →Sebastian

Ask Sam Okafor to introduce you to Sebastian

You →Sam · 10 people · together at PICUS CAPITAL →Sebastian

Your email: the people you already email who know Sebastian
2nd- and 3rd-degree connections: people you know who worked, studied or invested with Sebastian
Your LinkedIn: the connections who can make the intro for you

We rank every route by how warm it is, so you raise on warm intros instead of cold emails.

About

Sebastian Brunemeier is a biotech investor and company builder focused on longevity and regenerative medicine. He is Co-Founder and General Partner of Healthspan Capital and has co-founded multiple longevity biotech companies including Cambrian Biopharma, where he served as Chief Investment Officer, and Samsara Therapeutics, where he served as Founder and COO. His background includes a DPhil in biochemistry of aging from the University of Oxford (which he left to co-found Cambrian), an MSc in molecular neuroscience and life science business management from the University of Amsterdam, and fellowships focused on aging research from the Fulbright Program, Scripps Research Institute, and Buck Institute for Research on Aging.

Executive Officer, Director, Promoter at Cyclone Therapeutics

Intro paths

→

In turn, Sebastian can intro founders to Cyclone Therapeutics's investors below.

Cyclone Therapeutics's investors · 1

McKinsey & Companysince 2020

Experience

Healthspan CapitalCo-founder & Partnercurrent2021 — presentSan Francisco
LongGame VenturesVenture Partnercurrent2024 — presentLondon
Longevity Biotech FellowshipAdvisorcurrent2022 — presentSan Francisco, California, United States
Geneva College of Longevity ScienceFaculty Lecturercurrent2024 — presentGeneva, Switzerland
LongBio InstituteFoundercurrent2024 — presentUnited States
VitaDAOLongevity Working Groupcurrent2020 — presentSwitzerland
Longevity PrizeInitiator & Committee Membercurrent2022 — presentGlobal
Alpine InstituteAdvisory Boardcurrent2022 — presentZurich, Switzerland
Molecule AGAdvisorcurrent2020 — presentSwitzerland
Revivo TherapeuticsBoard Membercurrent2020 — presentChapel Hill, North Carolina, United States
Equator TherapeuticsAdvisory Board & Investorcurrent2020 — presentSan Francisco
Samsara TherapeuticsAdvisorcurrent2020 — present
Samsara TherapeuticsFounder & COO2018 — 2020Greater Oxford Area
Picus CapitalVenture Scoutcurrent2021 — present
ImmuneAGE BioCEO & Founder2022 — 2025US, Oxford UK & Lausanne CH
On DeckODLB -- Advisor & Founding Fellow - Longevity Biotech Fellowship2021 — 2023
McKinsey & CompanyAdvisor2019 — 2021Global
Cambrian BiopharmaCIO & Co-Founder2019 — 2020New York City
Cyclone TherapeuticsCEO & Co-Founder2019 — 2020La Jolla (San Diego)
Apollo Health VenturesPrincipal2018 — 2019Greater Hamburg Area
Deep Knowledge VenturesAssociate2016 — 2017London, United Kingdom
U.S. Department of StateFulbright Research Fellow2014 — 2015Lisbon, Portugal
Pascal ChemistryLab Manager2014Irvine, CA
CaltechResearch Assistant2013 — 2014Pasadena, CA
Buck Institute for Research on AgingSENS Research Foundation Scholar2012Novato, CA
Icahn School of Medicine at Mount SinaiThesis Research2011New York City

Skills & more

Venture CapitalDrug DiscoveryBiotechnologyMolecular BiologyProject ManagementBiochemistrySupercritical FluidsGraphPad PrismPublic SpeakingDebateMicrosoft ExcelMoney Laundering

+2 more

Creative AccountingExtortion

Languages Portuguese · Python · Spanish

Private Equity and Venture Capital — Università Bocconi
Fulbright Fellowship — U.S. Department of State
Neuropharmacology: Drugs and The Brain — Caltech
Econ 252: Financial Markets — Yale University

From Sebastian's professional profile.

Investments

Investor

Cyclone TherapeuticsJung+ LongevityOisin Biotechnologies

Per curated public sources.

Leave your own feedback

Colleagues at Healthspan Capital

Colin Maraganore

Partner at Bija Ventures

Frequently asked questions

Who is Sebastian Brunemeier?: Sebastian Brunemeier is a biotech investor and company builder focused on longevity and regenerative medicine. He is Co-Founder and General Partner of Healthspan Capital and has co-founded multiple longevity biotech companies including Cambrian Biopharma, where he served as Chief Investment Officer, and Samsara Therapeutics, where he served as Founder and COO. His background includes a DPhil in biochemistry of aging from the University of Oxford (which he left to co-found Cambrian), an MSc in molecular neuroscience and life science business management from the University of Amsterdam, and fellowships focused on aging research from the Fulbright Program, Scripps Research Institute, and Buck Institute for Research on Aging.
Where does Sebastian Brunemeier work?: Sebastian Brunemeier is General Partner at Healthspan Capital.
What check size does Sebastian Brunemeier write?: Sebastian Brunemeier typically writes checks of $250K – $750K.
What companies has Sebastian Brunemeier invested in?: Investments tracked here include Cyclone Therapeutics, Jung+ Longevity, Oisin Biotechnologies.
Where did Sebastian Brunemeier go to school?: Sebastian Brunemeier studied at University of Oxford (PhD (DPhil) studies (ABD), Biochemistry of aging. Clarendon Scholarship); Scripps Research (Skaggs-Oxford Scholar Fellowship (joint PhD program with Oxford, awarded but paused)); University of Amsterdam (MSc, Biomedical Science (Molecular Neuroscience)).